TABLE 3.
Comparison of amplicon sequencing performance in dual and single loci positive samples
| SARS-CoV-2 RT-qPCR (N and Orf1ab) |
No. samples | No. samples successfully sequenced (NTD and/or RBM) | % samples successfully sequenced |
|---|---|---|---|
| Dual loci positive (N and Orf1ab) | 379 | 306 | 80.7 |
| Single loci positive (N or Orf1ab) | 32 | 11 | 34.4 |
| Total | 411 | 317 | Avg 57.5 |